TERESA ROSE-HELLEKANT

Summary

Affiliation: University of Minnesota
Country: USA

Publications

  1. pmc Estrogen receptor-positive mammary tumorigenesis in TGFalpha transgenic mice progresses with progesterone receptor loss
    T A Rose-Hellekant
    Department of Pathobiological Sciences, University of Wisconsin Madison, Madison, WI, USA
    Oncogene 26:5238-46. 2007
  2. pmc Short-term prophylactic tamoxifen reduces the incidence of antiestrogen-resistant/estrogen receptor-positive/progesterone receptor-negative mammary tumors
    Teresa A Rose-Hellekant
    Department of Physiology and Pharmacology, University of Minnesota Medical School Duluth Campus, 1035 University Drive, Duluth, MN 55812, USA
    Cancer Prev Res (Phila) 2:496-502. 2009

Collaborators

Detail Information

Publications2

  1. pmc Estrogen receptor-positive mammary tumorigenesis in TGFalpha transgenic mice progresses with progesterone receptor loss
    T A Rose-Hellekant
    Department of Pathobiological Sciences, University of Wisconsin Madison, Madison, WI, USA
    Oncogene 26:5238-46. 2007
    ..Resulting tumors resemble a clinical phenotype of ER+/PR-, and when combined with a heterozygous p53 genotype, ER-/PR-...
  2. pmc Short-term prophylactic tamoxifen reduces the incidence of antiestrogen-resistant/estrogen receptor-positive/progesterone receptor-negative mammary tumors
    Teresa A Rose-Hellekant
    Department of Physiology and Pharmacology, University of Minnesota Medical School Duluth Campus, 1035 University Drive, Duluth, MN 55812, USA
    Cancer Prev Res (Phila) 2:496-502. 2009
    ..This study validates the utility of NRL-TGFalpha mice for (a) identifying candidate biomarkers of efficacious tamoxifen chemoprevention and (b) modeling the evolution of tamoxifen resistance...